<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p17" style="overflow: hidden; position: relative; background-color: white; width: 908px; height: 1286px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_17{left:130px;bottom:1195px;letter-spacing:0.22px;}
#t2_17{left:804px;bottom:1195px;letter-spacing:0.13px;}
#t3_17{left:128px;bottom:1109px;letter-spacing:-0.18px;}
#t4_17{left:238px;bottom:1109px;letter-spacing:-0.21px;}
#t5_17{left:238px;bottom:1080px;letter-spacing:-0.01px;}
#t6_17{left:686px;bottom:1080px;letter-spacing:-0.01px;}
#t7_17{left:723px;bottom:1080px;}
#t8_17{left:734px;bottom:1080px;letter-spacing:-0.01px;}
#t9_17{left:238px;bottom:1061px;letter-spacing:-0.01px;}
#ta_17{left:238px;bottom:1041px;letter-spacing:-0.01px;}
#tb_17{left:238px;bottom:1022px;letter-spacing:-0.01px;}
#tc_17{left:141px;bottom:968px;letter-spacing:-0.01px;}
#td_17{left:143px;bottom:940px;letter-spacing:-0.01px;}
#te_17{left:211px;bottom:940px;letter-spacing:-0.01px;}
#tf_17{left:211px;bottom:924px;letter-spacing:-0.01px;}
#tg_17{left:211px;bottom:908px;letter-spacing:-0.01px;}
#th_17{left:211px;bottom:891px;letter-spacing:-0.17px;}
#ti_17{left:317px;bottom:940px;letter-spacing:-0.01px;}
#tj_17{left:433px;bottom:940px;letter-spacing:-0.01px;}
#tk_17{left:541px;bottom:940px;letter-spacing:-0.01px;}
#tl_17{left:541px;bottom:924px;letter-spacing:-0.01px;}
#tm_17{left:541px;bottom:908px;letter-spacing:-0.01px;}
#tn_17{left:541px;bottom:891px;letter-spacing:-0.01px;}
#to_17{left:541px;bottom:875px;letter-spacing:-0.01px;}
#tp_17{left:649px;bottom:940px;letter-spacing:-0.01px;}
#tq_17{left:649px;bottom:924px;letter-spacing:-0.01px;}
#tr_17{left:143px;bottom:838px;letter-spacing:-0.14px;}
#ts_17{left:211px;bottom:838px;letter-spacing:-0.01px;}
#tt_17{left:211px;bottom:819px;letter-spacing:0.13px;}
#tu_17{left:211px;bottom:800px;letter-spacing:-0.01px;}
#tv_17{left:317px;bottom:838px;letter-spacing:-0.01px;}
#tw_17{left:317px;bottom:819px;letter-spacing:-0.01px;}
#tx_17{left:317px;bottom:800px;letter-spacing:-0.01px;}
#ty_17{left:317px;bottom:780px;letter-spacing:-0.01px;}
#tz_17{left:317px;bottom:761px;letter-spacing:-0.01px;}
#t10_17{left:317px;bottom:741px;letter-spacing:-0.01px;}
#t11_17{left:317px;bottom:722px;letter-spacing:-0.01px;}
#t12_17{left:317px;bottom:702px;letter-spacing:-0.01px;}
#t13_17{left:433px;bottom:838px;letter-spacing:-0.01px;}
#t14_17{left:433px;bottom:819px;letter-spacing:0.13px;}
#t15_17{left:433px;bottom:800px;letter-spacing:-0.01px;}
#t16_17{left:433px;bottom:780px;letter-spacing:-0.01px;}
#t17_17{left:433px;bottom:761px;letter-spacing:-0.01px;}
#t18_17{left:433px;bottom:741px;letter-spacing:-0.01px;}
#t19_17{left:433px;bottom:722px;letter-spacing:-0.01px;}
#t1a_17{left:433px;bottom:702px;letter-spacing:-0.01px;}
#t1b_17{left:433px;bottom:683px;letter-spacing:-0.01px;}
#t1c_17{left:433px;bottom:664px;letter-spacing:-0.01px;}
#t1d_17{left:541px;bottom:838px;letter-spacing:-0.01px;}
#t1e_17{left:541px;bottom:819px;letter-spacing:0.13px;}
#t1f_17{left:541px;bottom:800px;letter-spacing:-0.01px;}
#t1g_17{left:541px;bottom:780px;letter-spacing:-0.01px;}
#t1h_17{left:541px;bottom:761px;letter-spacing:-0.01px;}
#t1i_17{left:541px;bottom:741px;letter-spacing:-0.01px;}
#t1j_17{left:649px;bottom:838px;letter-spacing:-0.01px;}
#t1k_17{left:649px;bottom:819px;letter-spacing:-0.01px;}
#t1l_17{left:649px;bottom:800px;letter-spacing:-0.01px;}
#t1m_17{left:143px;bottom:623px;letter-spacing:-0.15px;}
#t1n_17{left:211px;bottom:623px;letter-spacing:-0.01px;}
#t1o_17{left:211px;bottom:604px;letter-spacing:-0.01px;}
#t1p_17{left:211px;bottom:585px;letter-spacing:-0.01px;}
#t1q_17{left:211px;bottom:565px;letter-spacing:-0.01px;}
#t1r_17{left:211px;bottom:546px;letter-spacing:0.2px;}
#t1s_17{left:317px;bottom:623px;letter-spacing:-0.01px;}
#t1t_17{left:317px;bottom:604px;letter-spacing:-0.01px;}
#t1u_17{left:317px;bottom:585px;letter-spacing:-0.01px;}
#t1v_17{left:317px;bottom:565px;letter-spacing:-0.01px;}
#t1w_17{left:317px;bottom:546px;letter-spacing:-0.01px;}
#t1x_17{left:317px;bottom:526px;letter-spacing:-0.01px;}
#t1y_17{left:317px;bottom:507px;letter-spacing:-0.01px;}
#t1z_17{left:317px;bottom:487px;letter-spacing:-0.01px;}
#t20_17{left:433px;bottom:623px;letter-spacing:-0.01px;}
#t21_17{left:433px;bottom:604px;letter-spacing:-0.01px;}
#t22_17{left:433px;bottom:585px;letter-spacing:-0.01px;}
#t23_17{left:433px;bottom:565px;letter-spacing:-0.01px;}
#t24_17{left:433px;bottom:546px;letter-spacing:-0.01px;}
#t25_17{left:433px;bottom:526px;letter-spacing:-0.01px;}
#t26_17{left:433px;bottom:507px;letter-spacing:-0.01px;}
#t27_17{left:433px;bottom:487px;letter-spacing:-0.01px;}
#t28_17{left:433px;bottom:468px;letter-spacing:-0.01px;}
#t29_17{left:541px;bottom:623px;letter-spacing:-0.01px;}
#t2a_17{left:541px;bottom:604px;letter-spacing:-0.01px;}
#t2b_17{left:541px;bottom:585px;letter-spacing:-0.01px;}
#t2c_17{left:541px;bottom:565px;letter-spacing:-0.01px;}
#t2d_17{left:649px;bottom:623px;letter-spacing:-0.01px;}
#t2e_17{left:649px;bottom:604px;letter-spacing:-0.01px;}
#t2f_17{left:649px;bottom:585px;letter-spacing:-0.01px;}
#t2g_17{left:649px;bottom:565px;letter-spacing:-0.01px;}
#t2h_17{left:649px;bottom:546px;letter-spacing:-0.01px;}
#t2i_17{left:649px;bottom:526px;letter-spacing:-0.01px;}
#t2j_17{left:649px;bottom:507px;letter-spacing:-0.01px;}
#t2k_17{left:143px;bottom:428px;letter-spacing:-0.14px;}
#t2l_17{left:211px;bottom:428px;letter-spacing:-0.01px;}
#t2m_17{left:211px;bottom:409px;letter-spacing:0.13px;}
#t2n_17{left:211px;bottom:389px;letter-spacing:-0.01px;}
#t2o_17{left:211px;bottom:370px;letter-spacing:-0.01px;}
#t2p_17{left:317px;bottom:428px;letter-spacing:-0.01px;}
#t2q_17{left:317px;bottom:409px;letter-spacing:-0.01px;}
#t2r_17{left:317px;bottom:389px;letter-spacing:-0.01px;}
#t2s_17{left:317px;bottom:370px;letter-spacing:-0.01px;}
#t2t_17{left:317px;bottom:350px;letter-spacing:-0.01px;}
#t2u_17{left:317px;bottom:331px;letter-spacing:-0.01px;}
#t2v_17{left:317px;bottom:311px;letter-spacing:-0.01px;}
#t2w_17{left:317px;bottom:292px;letter-spacing:-0.01px;}
#t2x_17{left:317px;bottom:272px;letter-spacing:-0.01px;}
#t2y_17{left:317px;bottom:253px;letter-spacing:-0.14px;}
#t2z_17{left:433px;bottom:428px;letter-spacing:-0.01px;}
#t30_17{left:433px;bottom:409px;letter-spacing:0.13px;}
#t31_17{left:433px;bottom:389px;letter-spacing:-0.01px;}
#t32_17{left:433px;bottom:369px;letter-spacing:-0.12px;}
#t33_17{left:433px;bottom:350px;letter-spacing:-0.01px;}
#t34_17{left:433px;bottom:331px;letter-spacing:-0.01px;}
#t35_17{left:541px;bottom:428px;letter-spacing:-0.01px;}
#t36_17{left:541px;bottom:409px;letter-spacing:0.13px;}
#t37_17{left:541px;bottom:389px;letter-spacing:-0.01px;}
#t38_17{left:541px;bottom:370px;letter-spacing:-0.01px;}
#t39_17{left:541px;bottom:350px;letter-spacing:-0.01px;}
#t3a_17{left:541px;bottom:331px;letter-spacing:-0.01px;}
#t3b_17{left:649px;bottom:428px;letter-spacing:-0.01px;}
#t3c_17{left:649px;bottom:409px;letter-spacing:-0.01px;}
#t3d_17{left:649px;bottom:389px;letter-spacing:-0.01px;}
#t3e_17{left:143px;bottom:213px;letter-spacing:-0.15px;}
#t3f_17{left:211px;bottom:213px;letter-spacing:-0.01px;}
#t3g_17{left:211px;bottom:194px;letter-spacing:-0.01px;}
#t3h_17{left:211px;bottom:174px;letter-spacing:-0.01px;}
#t3i_17{left:211px;bottom:155px;letter-spacing:-0.01px;}
#t3j_17{left:211px;bottom:135px;letter-spacing:-0.01px;}
#t3k_17{left:317px;bottom:213px;letter-spacing:-0.01px;}
#t3l_17{left:317px;bottom:194px;letter-spacing:-0.01px;}
#t3m_17{left:317px;bottom:174px;letter-spacing:-0.01px;}
#t3n_17{left:317px;bottom:155px;letter-spacing:-0.01px;}
#t3o_17{left:317px;bottom:135px;letter-spacing:-0.01px;}
#t3p_17{left:317px;bottom:116px;letter-spacing:-0.01px;}
#t3q_17{left:433px;bottom:213px;letter-spacing:-0.01px;}
#t3r_17{left:433px;bottom:194px;letter-spacing:-0.01px;}
#t3s_17{left:433px;bottom:174px;letter-spacing:-0.01px;}
#t3t_17{left:433px;bottom:155px;letter-spacing:-0.01px;}
#t3u_17{left:433px;bottom:135px;letter-spacing:-0.01px;}
#t3v_17{left:433px;bottom:116px;letter-spacing:-0.01px;}
#t3w_17{left:541px;bottom:213px;letter-spacing:0.11px;}
#t3x_17{left:541px;bottom:194px;letter-spacing:-0.01px;}
#t3y_17{left:541px;bottom:174px;letter-spacing:-0.01px;}
#t3z_17{left:541px;bottom:155px;letter-spacing:-0.01px;}
#t40_17{left:541px;bottom:135px;letter-spacing:-0.15px;}
#t41_17{left:649px;bottom:213px;letter-spacing:-0.01px;}
#t42_17{left:649px;bottom:194px;letter-spacing:-0.01px;}
#t43_17{left:649px;bottom:174px;letter-spacing:-0.01px;}
#t44_17{left:649px;bottom:155px;letter-spacing:-0.01px;}
#t45_17{left:649px;bottom:135px;letter-spacing:-0.01px;}
#t46_17{left:649px;bottom:116px;letter-spacing:-0.01px;}
#t47_17{left:202px;bottom:69px;letter-spacing:0.23px;}

.s0_17{font-size:11px;font-family:NotoSans-Regular_7j-;color:#000;}
.s1_17{font-size:12px;font-family:NotoSans-Regular_7j-;color:#000;}
.s2_17{font-size:18px;font-family:NotoSans-Regular_7j-;color:#000;}
.s3_17{font-size:13px;font-family:NotoSans-Regular_7j-;color:#000;}
.s4_17{font-size:13px;font-family:NotoSans-Regular_7j-;color:#F78C00;}
.s5_17{font-size:14px;font-family:NotoSans-Regular_7j-;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts17" type="text/css" >

@font-face {
	font-family: NotoSans-Regular_7j-;
	src: url("fonts/NotoSans-Regular_7j-.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg17Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg17" style="-webkit-user-select: none;"><object width="908" height="1286" data="17/17.svg" type="image/svg+xml" id="pdf17" style="width:908px; height:1286px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_17" class="t s0_17">2.2. Basics of the methodology </span><span id="t2_17" class="t s1_17">17 </span>
<span id="t3_17" class="t s2_17">2.2.1. </span><span id="t4_17" class="t s2_17">Oxford evidence grading scheme (version 2009) </span>
<span id="t5_17" class="t s3_17">To classify the risk of bias of the identified studies, this guideline used the</span><span id="t6_17" class="t s4_17">Table </span><span id="t7_17" class="t s4_17">4 </span><span id="t8_17" class="t s3_17">The system of </span>
<span id="t9_17" class="t s3_17">the Oxford Centre for Evidence-based Medicine in the 2009 version is used. This system </span>
<span id="ta_17" class="t s3_17">provides for the classification of studies for various clinical questions (benefit of therapy, </span>
<span id="tb_17" class="t s3_17">prognostic significance, diagnostic value). </span>
<span id="tc_17" class="t s3_17">Table 4: Oxford evidence grading scheme (March 2009 version) </span>
<span id="td_17" class="t s3_17">Level </span><span id="te_17" class="t s3_17">Therapy / </span>
<span id="tf_17" class="t s3_17">Prevention, </span>
<span id="tg_17" class="t s3_17">Aetiology / </span>
<span id="th_17" class="t s5_17">Harm </span>
<span id="ti_17" class="t s3_17">Forecast </span><span id="tj_17" class="t s3_17">Diagnosis </span><span id="tk_17" class="t s3_17">differential </span>
<span id="tl_17" class="t s3_17">diagnosis / </span>
<span id="tm_17" class="t s3_17">symptom </span>
<span id="tn_17" class="t s3_17">prevalence </span>
<span id="to_17" class="t s3_17">study </span>
<span id="tp_17" class="t s3_17">Economic and decision </span>
<span id="tq_17" class="t s3_17">analyses </span>
<span id="tr_17" class="t s5_17">1a </span><span id="ts_17" class="t s3_17">SR (with </span>
<span id="tt_17" class="t s1_17">homogeneity </span>
<span id="tu_17" class="t s3_17">y) of RCTs </span>
<span id="tv_17" class="t s3_17">SR (with </span>
<span id="tw_17" class="t s3_17">homogeneity) </span>
<span id="tx_17" class="t s3_17">inception </span>
<span id="ty_17" class="t s3_17">cohort </span>
<span id="tz_17" class="t s3_17">studies; CDR </span>
<span id="t10_17" class="t s3_17">validated in </span>
<span id="t11_17" class="t s3_17">different </span>
<span id="t12_17" class="t s3_17">populations </span>
<span id="t13_17" class="t s3_17">SR (with </span>
<span id="t14_17" class="t s1_17">homogeneity </span>
<span id="t15_17" class="t s3_17">y) of Level 1 </span>
<span id="t16_17" class="t s3_17">diagnostic </span>
<span id="t17_17" class="t s3_17">studies; CDR </span>
<span id="t18_17" class="t s3_17">with 1b </span>
<span id="t19_17" class="t s3_17">studies from </span>
<span id="t1a_17" class="t s3_17">different </span>
<span id="t1b_17" class="t s3_17">clinical </span>
<span id="t1c_17" class="t s3_17">centers </span>
<span id="t1d_17" class="t s3_17">SR (with </span>
<span id="t1e_17" class="t s1_17">homogeneity </span>
<span id="t1f_17" class="t s3_17">y) of </span>
<span id="t1g_17" class="t s3_17">prospective </span>
<span id="t1h_17" class="t s3_17">cohort </span>
<span id="t1i_17" class="t s3_17">studies </span>
<span id="t1j_17" class="t s3_17">SR (with homogeneity) </span>
<span id="t1k_17" class="t s3_17">of Level 1economic </span>
<span id="t1l_17" class="t s3_17">studies </span>
<span id="t1m_17" class="t s5_17">1b </span><span id="t1n_17" class="t s3_17">Individual </span>
<span id="t1o_17" class="t s3_17">RCT (with </span>
<span id="t1p_17" class="t s3_17">narrow </span>
<span id="t1q_17" class="t s3_17">Confidence </span>
<span id="t1r_17" class="t s0_17">Intervals) </span>
<span id="t1s_17" class="t s3_17">Individual </span>
<span id="t1t_17" class="t s3_17">inception </span>
<span id="t1u_17" class="t s3_17">cohort study </span>
<span id="t1v_17" class="t s3_17">with &gt; 80 % </span>
<span id="t1w_17" class="t s3_17">follow-up; </span>
<span id="t1x_17" class="t s3_17">CDR validated </span>
<span id="t1y_17" class="t s3_17">in a single </span>
<span id="t1z_17" class="t s3_17">population </span>
<span id="t20_17" class="t s3_17">Validating </span>
<span id="t21_17" class="t s3_17">cohort study </span>
<span id="t22_17" class="t s3_17">with good </span>
<span id="t23_17" class="t s3_17">reference </span>
<span id="t24_17" class="t s3_17">standards; </span>
<span id="t25_17" class="t s3_17">or CDR </span>
<span id="t26_17" class="t s3_17">tested within </span>
<span id="t27_17" class="t s3_17">oneclinical </span>
<span id="t28_17" class="t s3_17">centre </span>
<span id="t29_17" class="t s3_17">Prospective </span>
<span id="t2a_17" class="t s3_17">cohort study </span>
<span id="t2b_17" class="t s3_17">with good </span>
<span id="t2c_17" class="t s3_17">follow-up </span>
<span id="t2d_17" class="t s3_17">Analysis based on </span>
<span id="t2e_17" class="t s3_17">clinically sensitive costs </span>
<span id="t2f_17" class="t s3_17">or alternatives; </span>
<span id="t2g_17" class="t s3_17">systematic review(s) of </span>
<span id="t2h_17" class="t s3_17">the evidence; and </span>
<span id="t2i_17" class="t s3_17">including multi-way </span>
<span id="t2j_17" class="t s3_17">sensitivity analyses </span>
<span id="t2k_17" class="t s5_17">2a </span><span id="t2l_17" class="t s3_17">SR (with </span>
<span id="t2m_17" class="t s1_17">homogeneity </span>
<span id="t2n_17" class="t s3_17">y) of cohort </span>
<span id="t2o_17" class="t s3_17">studies </span>
<span id="t2p_17" class="t s3_17">SR (with </span>
<span id="t2q_17" class="t s3_17">homogeneity) </span>
<span id="t2r_17" class="t s3_17">of either </span>
<span id="t2s_17" class="t s3_17">retrospective </span>
<span id="t2t_17" class="t s3_17">cohort </span>
<span id="t2u_17" class="t s3_17">studies or </span>
<span id="t2v_17" class="t s3_17">untreated </span>
<span id="t2w_17" class="t s3_17">control </span>
<span id="t2x_17" class="t s3_17">groups in </span>
<span id="t2y_17" class="t s5_17">RCTs </span>
<span id="t2z_17" class="t s3_17">SR (with </span>
<span id="t30_17" class="t s1_17">homogeneity </span>
<span id="t31_17" class="t s3_17">y) of Level </span>
<span id="t32_17" class="t s5_17">&gt; 2 </span>
<span id="t33_17" class="t s3_17">diagnostic </span>
<span id="t34_17" class="t s3_17">studies </span>
<span id="t35_17" class="t s3_17">SR (with </span>
<span id="t36_17" class="t s1_17">homogeneity </span>
<span id="t37_17" class="t s3_17">y) of Level </span>
<span id="t38_17" class="t s3_17">2b and </span>
<span id="t39_17" class="t s3_17">better </span>
<span id="t3a_17" class="t s3_17">studies </span>
<span id="t3b_17" class="t s3_17">SR (with homogeneity) </span>
<span id="t3c_17" class="t s3_17">of Level &gt;2 economic </span>
<span id="t3d_17" class="t s3_17">studies </span>
<span id="t3e_17" class="t s5_17">2b </span><span id="t3f_17" class="t s3_17">Individual </span>
<span id="t3g_17" class="t s3_17">cohort study </span>
<span id="t3h_17" class="t s3_17">(including </span>
<span id="t3i_17" class="t s3_17">quality </span>
<span id="t3j_17" class="t s3_17">RCT; eg, </span>
<span id="t3k_17" class="t s3_17">Retrospective </span>
<span id="t3l_17" class="t s3_17">cohort study </span>
<span id="t3m_17" class="t s3_17">or follow-up </span>
<span id="t3n_17" class="t s3_17">of untreated </span>
<span id="t3o_17" class="t s3_17">control </span>
<span id="t3p_17" class="t s3_17">patients in an </span>
<span id="t3q_17" class="t s3_17">Exploratory </span>
<span id="t3r_17" class="t s3_17">cohort study </span>
<span id="t3s_17" class="t s3_17">with good </span>
<span id="t3t_17" class="t s3_17">reference </span>
<span id="t3u_17" class="t s3_17">standards; </span>
<span id="t3v_17" class="t s3_17">CDR after </span>
<span id="t3w_17" class="t s1_17">Retrospective </span>
<span id="t3x_17" class="t s3_17">e cohort </span>
<span id="t3y_17" class="t s3_17">study, or </span>
<span id="t3z_17" class="t s3_17">poor follow- </span>
<span id="t40_17" class="t s5_17">up </span>
<span id="t41_17" class="t s3_17">Analysis based on </span>
<span id="t42_17" class="t s3_17">clinically sensitive costs </span>
<span id="t43_17" class="t s3_17">or alternatives; limited </span>
<span id="t44_17" class="t s3_17">review(s) of the </span>
<span id="t45_17" class="t s3_17">evidence, or single </span>
<span id="t46_17" class="t s3_17">studies; and including </span>
<span id="t47_17" class="t s0_17">Â© Oncology Guideline Program | S3 Guideline Laryngeal Carcinoma | Long Version 1.0 | January 2019 </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
